SEC Form 4 · accession 0000899243-17-007012
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
William F Doyle
Officer — Executive Chairman · Director · 10% Owner
WFD Ventures Fund II, L.P.
10% Owner
Period of report
Mar 8, 2017
Accepted (ET)
Mar 9, 2017 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Mar 8, 2017 | J | 19,732,767 | — | D | 43,000 | I | WFD Ventures Fund II, L.P. |
| Ordinary Shares | holding | — | — | — | 84,699 | D | ||
| Ordinary SharesF1,F2 | holding | — | — | — | 625,954 | I | WFD-GP II, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 8, 2017, WFD Ventures Fund II, L.P. distributed, on a pro-rata basis and without consideration, to its economic partners 19,732,767 of the Issuer's shares, including 625,954 of such shares to WFD-GP II, LLC.
- F2Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.